Is High roughput Glycomics Possible ?

The role of glycosylation and their biological functions whether as free oligosaccharides or glycoconjugates has been made possible by the recent advancements in the analyses of these compounds. The heterogeneity and the large structural diversity have made oligosaccharide analysis significantly more difficult than other biopolymers. The next stage of development is to achieve high throughput analysis. However, the structural elucidation of oligosaccharides remains an extremely difficult task. Recent reports reveal that the diversity of structures in a given biological system is finite and may not be large. It may be possible to create a database of structures that can be used to determine the identity of known compounds. This capability would therefore make high throughput glycomics possible. Achieving this task depends on the proper selection of chemical characteristics to identify the compound. In this presentation, nanoflow liquid chromatography retention times, accurate mass, and tandem MS is used to determine structure with a high degree of certainty. The method is used to determine the biological function of milk oligosaccharides as well as to discover glycan-based biomarkers for diseases.

[1]  Scott R. Kronewitter,et al.  Glycomics and disease markers. , 2009, Current opinion in chemical biology.

[2]  C. Lebrilla,et al.  Post-translation modifications. , 2009, Current Opinion in Chemical Biology.

[3]  Pauline M Rudd,et al.  Ovarian cancer is associated with changes in glycosylation in both acute-phase proteins and IgG. , 2007, Glycobiology.

[4]  Salvatore Fanali,et al.  Recent applications in nanoliquid chromatography. , 2007, Journal of separation science.

[5]  David C Muddiman,et al.  Epithelial ovarian cancer: disease etiology, treatment, detection, and investigational gene, metabolite, and protein biomarkers. , 2007, Journal of proteome research.

[6]  Y. Mechref,et al.  Alterations in the serum glycome due to metastatic prostate cancer. , 2007, Journal of proteome research.

[7]  D. Simeone,et al.  N-linked glycosylation profiling of pancreatic cancer serum using capillary liquid phase separation coupled with mass spectrometric analysis. , 2007, Journal of proteome research.

[8]  Kit S. Lam,et al.  A Serum Glycomics Approach to Breast Cancer Biomarkers*S , 2007, Molecular & Cellular Proteomics.

[9]  Rudolf Grimm,et al.  A strategy for annotating the human milk glycome. , 2006, Journal of agricultural and food chemistry.

[10]  Y. Mechref,et al.  Miniaturized separation techniques in glycomic investigations. , 2006, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[11]  Kit S Lam,et al.  Profiling of glycans in serum for the discovery of potential biomarkers for ovarian cancer. , 2006, Journal of proteome research.

[12]  Carlito Lebrilla,et al.  Nanoliquid chromatography‐mass spectrometry of oligosaccharides employing graphitized carbon chromatography on microchip with a high‐accuracy mass analyzer , 2005, Electrophoresis.

[13]  C. Bertozzi,et al.  Glycans in cancer and inflammation — potential for therapeutics and diagnostics , 2005, Nature Reviews Drug Discovery.

[14]  Hyun Joo An,et al.  Improved capillary electrophoretic separation and mass spectrometric detection of oligosaccharides. , 2003, Journal of chromatography. A.

[15]  R. Spiro.  Protein glycosylation: nature, distribution, enzymatic formation, and disease implications of glycopeptide bonds. , 2002, Glycobiology.

[16]  C. Lebrilla,et al.  Infrared multiphoton dissociation mass spectrometry for structural elucidation of oligosaccharides. , 2009, Methods in molecular biology.

[17]  Carlito B. Lebrilla,et al.  The prospects of glycan biomarkers for the diagnosis of diseases. , 2009, Molecular bioSystems.

[18]  Kiyoko F. Aoki-Kinoshita,et al.  Frontiers in glycomics: Bioinformatics and biomarkers in disease An NIH White Paper prepared from discussions by the focus groups at a workshop on the NIH campus, Bethesda MD (September 11–13, 2006) , 2008, Proteomics.